Canada markets open in 8 hours 54 minutes

Aptose Biosciences Inc. (APTO)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.15000.0000 (0.00%)
At close: 04:00PM EDT
1.1600 +0.01 (+0.87%)
After hours: 07:57PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-47,171
-51,207
-41,823
-65,354
-55,238
-
Depreciation & amortization
444
466
528
622
614
-
Stock based compensation
2,588
3,653
5,207
12,949
21,438
-
Change in working capital
-621
2,810
4,317
1,516
-262
-
Accounts Payable
-3,098
-280
7,611
-472
211
-
Other working capital
-45,080
-44,619
-32,346
-43,516
-33,970
-
Other non-cash items
-304
-312
-571
6,970
-435
-
Net cash provided by operating activites
-45,051
-44,590
-32,322
-43,304
-33,891
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-29
-24
-212
-79
-
Purchases of investments
-
-
-
-34,996
-
-17,268
Sales/Maturities of investments
-
-
-
-
12,707
-
Net cash used for investing activites
10,929
9,960
30,066
-35,208
12,628
-
Cash flows from financing activities
Common stock issued
18,676
6,881
101
36
58,402
-
Other financing activites
-
-
-
-
-168
-437
Net cash used privided by (used for) financing activities
18,707
6,910
116
226
58,807
-
Net change in cash
-15,416
-27,718
-2,144
-78,279
37,551
-
Cash at beginning of period
22,762
36,970
39,114
117,393
79,842
-
Cash at end of period
7,347
9,252
36,970
39,114
117,393
-
Free Cash Flow
Operating Cash Flow
-45,051
-44,590
-32,322
-43,304
-33,891
-
Capital Expenditure
-
-29
-24
-212
-79
-
Free Cash Flow
-45,080
-44,619
-32,346
-43,516
-33,970
-